Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Assets    
Financing receivables $ 1,062,051 $ 1,042,237
Investments 130,540 58,058
Real estate 313,642 172,257
Equity method investments 540,150 363,297
Cash and cash equivalents 90,752 29,428
Other assets 173,550 80,610
Total Assets 2,310,685 1,745,887
Liabilities:    
Accounts payable, accrued expenses and other 33,187 25,219
Deferred funding obligations 225,817 170,892
Credit facilities 174,742 283,346
Non-recourse debt (secured by assets of $1,416 million and $864 million, respectively) 1,076,326 692,091
Convertible notes 145,914  
Total Liabilities 1,655,986 1,171,548
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 51,656,224 and 46,493,155 shares issued and outstanding, respectively 517 465
Additional paid in capital 768,665 663,744
Accumulated deficit (117,122) (92,213)
Accumulated other comprehensive income (loss) (1,009) (1,388)
Non-controlling interest 3,648 3,731
Total Stockholders' Equity 654,699 574,339
Total Liabilities and Stockholders' Equity $ 2,310,685 $ 1,745,887